Polyamine acetylation and apoptosis

1996 ◽  
Vol 24 (2) ◽  
pp. 229S-229S
Author(s):  
Gayle S Lindsay ◽  
Heather M Wallace
1983 ◽  
Vol 1 (3) ◽  
pp. 179-185 ◽  
Author(s):  
José G. Ortiz ◽  
Ezio Giacobini ◽  
Thomas Schmidt-Glenewinkel

2007 ◽  
Vol 283 (7) ◽  
pp. 4241-4251 ◽  
Author(s):  
Debora L. Kramer ◽  
Paula Diegelman ◽  
Jason Jell ◽  
Slavoljub Vujcic ◽  
Salim Merali ◽  
...  

1990 ◽  
Vol 18 (6) ◽  
pp. 1091-1094 ◽  
Author(s):  
HEATHER M. WALLACE ◽  
CATHERINE S. COLEMAN

1995 ◽  
Vol 97 (1) ◽  
pp. 123-128
Author(s):  
Angela Sessa ◽  
Patrizia Tunici ◽  
Antonio Perin

Viruses ◽  
2021 ◽  
Vol 13 (2) ◽  
pp. 310
Author(s):  
Bridget M. Hulsebosch ◽  
Bryan C. Mounce

Enteroviruses, including Coxsackievirus B3 (CVB3), are pervasive pathogens that cause significant disease, including cardiomyopathies. Unfortunately, no treatments or vaccines are available for infected individuals. We identified the host polyamine pathway as a potential drug target, as inhibiting polyamine biosynthesis significantly reduces enterovirus replication in vitro and in vivo. Here, we show that CVB3 is sensitive to polyamine depletion through the polyamine analog diethylnorspermidine (DENSpm), which enhances polyamine catabolism through induction of polyamine acetylation. We demonstrate that CVB3 acquires resistance to DENSpm via mutation of the 2A protease, which enhances proteolytic activity in the presence of DENSpm. Resistance to DENSpm occurred via mutation of a non-catalytic site mutation and results in decreased fitness. These data demonstrate that potential for targeting polyamine catabolism as an antiviral target as well as highlight a potential mechanism of resistance.


1997 ◽  
Vol 28 ◽  
pp. S177
Author(s):  
Yasushi Hayashi ◽  
Junichi Tanaka ◽  
Hiroichi Imazu

Author(s):  
E.W. Gerner ◽  
S.W. Carper ◽  
D. Willis ◽  
J. Fish ◽  
K. Manning ◽  
...  
Keyword(s):  
E Coli ◽  

Sign in / Sign up

Export Citation Format

Share Document